Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

BEIJING (Reuters) -China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain ...

China's AI race is heating up, with new models making waves in the industry. One new contender is Manus, an AI agent being hailed as the next potential "DeepSeek moment." Here are five key players ...

Regeneron Pharmaceuticals Inc (NASDAQ:REGN). has reached an unprecedented milestone as its stock soared to an all-time high of... ByInvesting.com • Aug 26, 2024 Regeneron shares reiterated at ...

Elon Musk has shared a video of re-designed Tesla's new Model Y on X, formerly known as Twitter. The Model Y offers innovative storage solutions with power-reclining seats and an expanded cargo ...

Regeneron Pharmaceuticals moved higher after promising results from a clinical trial of Dupixent for the treatment of a rare ... amid signs of softening demand for the company's Model 3 and Model Y ...

Microsoft is developing in-house artificial intelligence reasoning models to compete with OpenAI and may sell them to developers, The Information reported on Friday, citing a person involved in this ...

The study met its primary endpoint, but analysts compared the results unfavorably to the data on Dupixent. Adjusted for placebo, 19.1% of people on rocatinlimab had 75% improvement in eczema area ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly ...

Large language models work well because they’re so large. The latest models from OpenAI, Meta and DeepSeek use hundreds of billions of “parameters” — the adjustable knobs that determine connections ...